Maxim Group starts Telomir Pharmaceuticals with Buy rating
Maxim Group initiated coverage of Telomir Pharmaceuticals (ticker: TELO) with a Buy rating,
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.